Javascript must be enabled to continue!
Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission v1
View through CrossRef
Background: Proteinuria is a powerful prognostic factor for end-stage renal disease in IgA nephropathy (IgAN) patients. However, it is not known whether proteinuria exacerbations are related to seasonal changes. Methods: We retrospectively enrolled consecutive patients diagnosed with IgAN by kidney biopsy at our hospital between 2002 and 2014. Proteinuria remission was defined as urinary protein <0.3 g/gCr in two consecutive outpatient urinalyses and exacerbation as urinary protein 竕・0.75 g/gCr. Four seasons were defined: spring (March- May), summer (June- August), autumn (September- November), and winter (December- February). We performed a multivariate analysis to identify factors associated with the second remission following a proteinuria exacerbation. Results: We analyzed 116 patients. Proteinuria remission and exacerbation occurred in 89, and 50 patients, respectively. The incidence of proteinuria exacerbation was significantly higher in autumn and winter than in spring and summer (p=0.040). The cumulative second remission rate was significantly higher in patients with autumn and winter proteinuria exacerbation than in patients with spring and summer exacerbations (p=0.010). In multivariate analyses, exacerbation onset in autumn and winter (HR, 3.36; 95% CI, 1.36- 8.34) and intensive therapy (HR, 2.68; 95% CI, 1.24- 5.80) were significantly associated with a second proteinuria remission. Conclusion: In IgAN patients in proteinuria remission, proteinuria exacerbation frequently occurred in autumn and winter. Exacerbations occurring in autumn and winter tended to remit early.
Title: Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission v1
Description:
Background: Proteinuria is a powerful prognostic factor for end-stage renal disease in IgA nephropathy (IgAN) patients.
However, it is not known whether proteinuria exacerbations are related to seasonal changes.
Methods: We retrospectively enrolled consecutive patients diagnosed with IgAN by kidney biopsy at our hospital between 2002 and 2014.
Proteinuria remission was defined as urinary protein <0.
3 g/gCr in two consecutive outpatient urinalyses and exacerbation as urinary protein 竕・0.
75 g/gCr.
Four seasons were defined: spring (March- May), summer (June- August), autumn (September- November), and winter (December- February).
We performed a multivariate analysis to identify factors associated with the second remission following a proteinuria exacerbation.
Results: We analyzed 116 patients.
Proteinuria remission and exacerbation occurred in 89, and 50 patients, respectively.
The incidence of proteinuria exacerbation was significantly higher in autumn and winter than in spring and summer (p=0.
040).
The cumulative second remission rate was significantly higher in patients with autumn and winter proteinuria exacerbation than in patients with spring and summer exacerbations (p=0.
010).
In multivariate analyses, exacerbation onset in autumn and winter (HR, 3.
36; 95% CI, 1.
36- 8.
34) and intensive therapy (HR, 2.
68; 95% CI, 1.
24- 5.
80) were significantly associated with a second proteinuria remission.
Conclusion: In IgAN patients in proteinuria remission, proteinuria exacerbation frequently occurred in autumn and winter.
Exacerbations occurring in autumn and winter tended to remit early.
Related Results
Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Abstract
Chemical and functional properties of IgA binding factor(s) (IgA-BF) from both murine Con A-activated spleen cells and Fc gamma R+, Fc alpha R+ T hybridoma ...
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
AbstractBecause abnormalities of mucosal immunity have been suggested in human IgA nephropathy, we examined the involvement of mucosal immunity in IgA deposition to the kidney in h...
Etiology of IgA nephropathy syndrome
Etiology of IgA nephropathy syndrome
Since Berger's original paper on mesangial IgA‐IgG deposition with hematuria, there have been a number of clinical and pathological studies regarding IgA immune complexes, the mech...
An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti‐IgA) and IgA deficiency
An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti‐IgA) and IgA deficiency
BACKGROUND: Immunoglobulin A antibodies (anti‐IgA) are rare but can cause transfusion‐associated anaphylaxis. The detection of anti‐IgA has traditionally been performed using a lab...
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
ABSTRACTObjectives:The aim was to investigate age‐dependent serum levels and occurrence of elevated celiac disease (CD)–related antibodies in young children, to define the optimal ...
MO205: The Outcome of Patients Without Nephrotic Syndrome (NS) is Not Different From Patients With NS, WHO Were Diagnosed as Minimal Change Lesion
MO205: The Outcome of Patients Without Nephrotic Syndrome (NS) is Not Different From Patients With NS, WHO Were Diagnosed as Minimal Change Lesion
Abstract
BACKGROUND AND AIMS
Minimal change lesion (MCD) accounts for 10–15% of adult patients with nephrotic syndrome and is ch...
Resistance of Normal Serum IgA and Secretory IgA to Bacterial IgA Proteases: Evidence for the Presence of Enzyme‐Neutralizing Antibodies in Both Serum and Secretory IgA, and Also in Serum IgG
Resistance of Normal Serum IgA and Secretory IgA to Bacterial IgA Proteases: Evidence for the Presence of Enzyme‐Neutralizing Antibodies in Both Serum and Secretory IgA, and Also in Serum IgG
AbstractNormal serum IgA and secretory IgA (sIgA) of subclass IgA1 were isolated from pooled human serum and milk, respectively. They were tested for their susceptibility to bacter...
Effects of serial plasmapheresis on serum IgA levels in IgA‐deficient blood donors with IgA‐suppressor T cells
Effects of serial plasmapheresis on serum IgA levels in IgA‐deficient blood donors with IgA‐suppressor T cells
Seventeen IgA‐deficient blood donors, without antibodies to IgA, underwent plasmapheresis four to eight consecutive times at intervals of 8 weeks or less to provide fresh‐frozen pl...

